本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Arcus Biosciences Inc.

24.65
+0.33001.36%
盤後24.700.0500+0.20%17:40 EDT
成交量:229.55萬
成交額:5,678.25萬
市值:31.39億
市盈率:-6.38
高:25.28
開:24.79
低:24.18
收:24.32
52周最高:31.74
52周最低:11.58
股本:1.27億
流通股本:8,983.64萬
量比:0.95
換手率:2.56%
股息:- -
股息率:- -
每股收益(TTM):-3.8641
每股收益(LYR):-3.2900
淨資產收益率:-90.82%
總資產收益率:-30.39%
市淨率:6.76
市盈率(LYR):-7.49

資料載入中...

2024/01/30

重要事件披露

Form 8-K - Current report
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/09/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/07

重要事件披露

Form 8-K - Current report
2023/07/06

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/28

重要事件披露

Form 8-K - Current report
2023/06/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities